The POC (point-of-care) diagnostics market stands at about $18.8 billion globally, according to recent market trends, and is expected to grow by a third to $24.1 billion this year and projected to explode by 2024 to $46.7 billion. The main driver for these highly optimistic forecasts is the surge in healthcare technology demand brought on by the
DARPA资助的新技术有望通过植入式生物芯片诊断COVID-19
由斯坦福大学开发并由BARDA和DARPA资助的新型mRNA诊断工具正在使可植入生物芯片技术更加接近现实。